Gary Clifton, a director at Terumo, discusses vascular access and Terumo's product portfolio. He notes that while transradial access has clear clinical benefits over femoral access like lower bleeding risks, not all procedures can be done radially. As such, Terumo has developed products like its Slender and Pinnacle Precision micro-access tools to improve safety for alternative access points. Terumo has also developed expandable sheath technologies like SoloPath that allow removal of large bore dilators to minimize vascular complications when femoral access is needed, such as for transcatheter aortic valve replacements.